Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
about
Role of T cells in type 2 diabetic nephropathyOmega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidneyUrinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity.Regulatory activity of polyunsaturated fatty acids in T-cell signaling.Signaling pathways modulated by fish oil in salt-sensitive hypertensionThe {omega}-3 fatty acid eicosapentaenoic acid elicits cAMP generation in colonic epithelial cells via a "store-operated" mechanism.n-3 Fatty acids block TNF-α-stimulated MCP-1 expression in rat mesangial cells.Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidneyThe effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials.Role of N-acetyl-seryl-aspartyl-lysyl-proline in the antifibrotic and anti-inflammatory effects of the angiotensin-converting enzyme inhibitor captopril in hypertensionSignaling mechanisms in the regulation of renal matrix metabolism in diabetes.Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia.Effect of exercise on kidney function, oxidative stress, and inflammation in type 2 diabetic KK-A(y) miceMonocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetesLessons From the KK-Ay Mouse, a Spontaneous Animal Model for the Treatment of Human Type 2 Diabetic NephropathyDNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathy.Effects of polyunsaturated fatty acid consumption in diabetic nephropathy.What are new avenues for renal protection, in addition to RAAS inhibition?KLF15 suppresses cell proliferation and extracellular matrix expression in mesangial cells under high glucose.Effect of omega 3 fatty acids plus low-dose aspirin on both clinical and biochemical profiles of patients with chronic periodontitis and type 2 diabetes: a randomized double blind placebo-controlled study.Effect of the Direct Renin Inhibitor Aliskiren on Urinary Albumin Excretion in Spontaneous Type 2 Diabetic KK-A (y) Mouse.Eicosapentaenoic acid restores diabetic tubular injury through regulating oxidative stress and mitochondrial apoptosis.Omacor, n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animals.Omega-3 fatty acid rich diet prevents diabetic renal disease.Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice.Dietary flaxseed oil and fish oil ameliorates renal oxidative stress, protein glycation, and inflammation in streptozotocin-nicotinamide-induced diabetic rats.Pathogenesis and novel treatment from the mouse model of type 2 diabetic nephropathy
P2860
Q26849691-7F632F06-34F7-4DB1-BC00-C3253AFF514EQ28570995-C7A2B403-86D3-44FA-9748-203507E74CF3Q33828918-07B36AA2-ECF9-42E2-9E1B-B6542A0AB230Q33860669-30412D7D-D827-4344-B052-EE5E964C6607Q33887250-CCE85E7D-B950-43D0-AA06-6F8F149D084AQ34178830-F60BEEB2-1F44-4FE4-8069-1219CE9DB569Q34979637-B5897421-FD3E-47AA-AFB2-4EC807C5EFF9Q35026645-0AE88C4A-8CB8-48D9-B605-7B5EC5131087Q35140612-D2B0BFA9-DA3E-4A64-A3D3-9AEB8027087AQ35670580-FEB20A23-D8E0-411F-9B14-0911B7669BF5Q35791976-1A207AF3-2E61-4AA5-B4D4-86A23EC2AE34Q36005146-F057FE6B-E0E2-4AD5-9A6B-8138877305D8Q36140981-86BE2E19-9101-48B4-A055-6F0CCF40C354Q36222092-9FF095DE-DBCD-4063-BBEE-AE44CD88AE90Q36734406-07C638C6-0845-49FD-8973-E0EAB383D1B8Q37110641-D613E70B-D734-4C11-AAF5-8CEC9CF66505Q37816963-49EAF3BF-74A2-439C-8A9A-86D3E9D48AD2Q37980677-32FDDFDE-D991-4BBA-8819-BD3384C25314Q39991587-5272D960-6FBB-489B-9A3C-92E9BC275F26Q41554270-8D7EF36D-3257-4E0B-A206-BE80658287AAQ41852636-98C47BCD-0B3E-4F73-B2C8-78EA77B3FF4FQ42906415-3E09954D-AE05-491A-BA63-6D3F58895213Q43204665-3913D11D-05F6-48DA-B5A9-FBBD3B9943A9Q46217499-030FA001-3D28-4560-A088-4EF38F15BFACQ53061535-1800682E-912A-4A04-937F-6D2CCCA7281AQ53129191-309A16BC-DAE4-445B-9998-EA12047C70E3Q59034810-70BDA5D5-E9C5-4855-AE7F-0E02007F62CE
P2860
Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Eicosapentaenoic acid ameliora ...... RK1/2 and p38 phosphorylation.
@en
Eicosapentaenoic acid ameliora ...... RK1/2 and p38 phosphorylation.
@nl
type
label
Eicosapentaenoic acid ameliora ...... RK1/2 and p38 phosphorylation.
@en
Eicosapentaenoic acid ameliora ...... RK1/2 and p38 phosphorylation.
@nl
prefLabel
Eicosapentaenoic acid ameliora ...... RK1/2 and p38 phosphorylation.
@en
Eicosapentaenoic acid ameliora ...... RK1/2 and p38 phosphorylation.
@nl
P2093
P2860
P356
P1476
Eicosapentaenoic acid ameliora ...... RK1/2 and p38 phosphorylation.
@en
P2093
Minfang Zhang
Mitsuo Tanimoto
Satoshi Horikoshi
Shigeru Kaneko
Shinji Hagiwara
Shinji Nakamura
Takamichi Itoh
Tomohito Gohda
Yasuhiko Tomino
P2860
P304
P356
10.1093/NDT/GFI208
P407
P577
2005-11-10T00:00:00Z